Skip to main content
SpringerLink
Log in

Brève de l’AERIO

Paclitaxel et trastuzumab en adjuvant dans les cancers du sein surexprimant HER2 sans atteinte ganglionnaire

AERIO news in brief

Adjuvant paclitaxel and trastuzumab for node-negative, HER2-positive breast cancer

  • Revue de Presse de L’Aerio / Aerio Press Review
  • Published:
Oncologie

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Références

  1. Gonzalez-Angulo AM, Litton JK, Broglio KR, et al. (2009) High risk of recurrence for patients with breast cancer who have human epidermal growth factor receptor 2-positive, node-negative tumors 1 cm or smaller. J Clin Oncol 27: 5700–6

    Article  PubMed Central  PubMed  Google Scholar 

  2. Slamon DJ, Clark GM, Wong SG, et al. (1987) Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 235: 177–82

    Article  CAS  PubMed  Google Scholar 

  3. Slamon D, Eiermann W, Robert N, et al. (2011) Adjuvant trastuzumab in HER2-positive breast cancer. N Engl J Med 365: 1273–83

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  4. Jones SE, Collea R, Paul D, et al. (2013) Adjuvant docetaxel and cyclophosphamide plus trastuzumab in patients with HER2-amplified early stage breast cancer: a single-group, open-label, phase II study. Lancet Oncol 14: 1121–8

    Article  CAS  PubMed  Google Scholar 

  5. Tolaney SM, Barry WT, Dang CT, et al. (2015) Adjuvant paclitaxel and trastuzumab for node-negative, HER2-positive breast cancer. N Engl J Med 372: 134–41

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  6. Rodrigues MJ, Peron J, Frénel JS, et al. (2013) Benefit of adjuvant trastuzumab-based chemotherapy in T1ab node-negative HER2-overexpressing breast carcinomas: a multicenter retrospective series. Ann Oncol 24: 916–24

    Article  CAS  PubMed  Google Scholar 

  7. McArthur HL, Mahoney KM, Morris PG, et al. (2011) Adjuvant trastuzumab with chemotherapy is effective in women with small, node-negative, HER2-positive breast cancer. Cancer 117: 5461–8

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Institut Curie, 26, rue d’Ulm, F-75005, Paris, France

    D. Cochereau & P. Cottu

Authors
  1. D. Cochereau
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. P. Cottu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to D. Cochereau.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Cochereau, D., Cottu, P. Brève de l’AERIO. Oncologie 17, 194–196 (2015). https://doi.org/10.1007/s10269-015-2511-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10269-015-2511-6

Search

Navigation